Reflux inhibitors - new therapy of gastroesophageal reflux disease

被引：0
|
作者：
Jurkowska, Grazyna [1 ]
Swidnicka-Siergiejko, Agnieszka [1 ]
Dabrowski, Andrzej [1 ]
机构：
[1] Uniwersytet Med Bialymstoku, Klin Gastroenterol & Chorob Wewnetrznych, PL-15276 Bialystok, Poland
来源：
PRZEGLAD GASTROENTEROLOGICZNY | 2012年 / 7卷 / 02期
关键词：
gastroesophageal reflux; transient lower esophageal sphincter relaxation; GABA receptors; glutamate receptors; ESOPHAGEAL SPHINCTER RELAXATIONS; NEGATIVE ALLOSTERIC MODULATOR; AGONIST BACLOFEN; SYMPTOMS; ADX10059; ACID; IMPEDANCE; EFFICACY; HERNIA;
D O I：
10.5114/pg.2012.28645
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
The most relevant target for the treatment of refractory gastroesophageal reflux disease (GERD) is controlling the occurrence of transient lower esophageal relaxations (TLESR), which represent the main mechanism of all types of reflux. Drugs in development that have this mechanism of action are now described as reflux inhibitors. The most promising among these appear to be mGluR5 agonists and GABA(B) receptor agonists, which reduce the number of reflux episodes and improve reflux-related symptoms. Reflux inhibitors appear to have a potential role in the management of refractory GERD as add-on therapy in combination with PPI. Future studies will establish the safety and tolerability of the new anti-reflux therapy.
引用
收藏
页码：57 / 62
页数：6
相关论文
共 50 条
  • [1] THERAPY OF GASTROESOPHAGEAL REFLUX DISEASE
    GULLER, R
    [J]. SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1980, 110 (42) : 1538 - 1541
  • [2] Therapy Insight: gastroesophageal reflux disease and laryngopharyngeal reflux
    Vaezi, MF
    [J]. NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY, 2005, 2 (12): : 595 - 603
  • [3] Therapy Insight: gastroesophageal reflux disease and laryngopharyngeal reflux
    Michael F Vaezi
    [J]. Nature Clinical Practice Gastroenterology & Hepatology, 2005, 2 : 595 - 603
  • [4] THERAPY FOR GASTROESOPHAGEAL REFLUX DISEASE - THE NEW KID ON THE BLOCK
    PELLEGRINI, CA
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 1995, 180 (04) : 485 - 487
  • [5] New developments in gastroesophageal reflux disease diagnosis and therapy
    Ali, Tauseef
    Miner, Philip B., Jr.
    [J]. CURRENT OPINION IN GASTROENTEROLOGY, 2008, 24 (04) : 502 - 508
  • [6] Mechanisms of gastroesophageal reflux and gastroesophageal reflux disease
    Vandenplas, Y
    Hassall, T
    [J]. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2002, 35 (02): : 119 - 136
  • [7] Endoscopic anti-reflux therapy for gastroesophageal reflux disease
    Rodriguez de Santiago, Enrique
    Albeniz, Eduardo
    Estremera-Arevalo, Fermin
    Teruel Sanchez-Vegazo, Carlos
    Lorenzo-Zuniga, Vicente
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2021, 27 (39) : 6601 - 6614
  • [8] Endoscopic anti-reflux therapy for gastroesophageal reflux disease
    Enrique Rodríguez de Santiago
    Eduardo Albéniz
    Fermin Estremera-Arevalo
    Carlos Teruel Sanchez-Vegazo
    Vicente Lorenzo-Zú?iga
    [J]. World Journal of Gastroenterology, 2021, (39) : 6601 - 6614
  • [9] MAINTENANCE THERAPY IN GASTROESOPHAGEAL REFLUX DISEASE
    ORR, WC
    [J]. HOSPITAL FORMULARY, 1992, 27 (05): : 504 - &
  • [10] Maintenance therapy of gastroesophageal reflux disease
    Nagahara A.
    Hojo M.
    Asaoka D.
    Watanabe S.
    [J]. Clinical Journal of Gastroenterology, 2010, 3 (2) : 61 - 68
12345